Positive News Coverage Somewhat Unlikely to Impact Blackrock Health Sciences Trust (BME) Share Price
News stories about Blackrock Health Sciences Trust (NYSE:BME) have been trending positive recently, Accern Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Blackrock Health Sciences Trust earned a news impact score of 0.49 on Accern’s scale. Accern also gave news articles about the company an impact score of 44.9822098625374 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Shares of Blackrock Health Sciences Trust (NYSE BME) opened at $36.38 on Friday. Blackrock Health Sciences Trust has a 52-week low of $31.55 and a 52-week high of $38.00.
The firm also recently declared a monthly dividend, which will be paid on Friday, December 29th. Shareholders of record on Friday, December 15th will be issued a $0.20 dividend. This represents a $2.40 annualized dividend and a yield of 6.60%. The ex-dividend date of this dividend is Thursday, December 14th.
WARNING: This report was reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this report on another domain, it was illegally copied and reposted in violation of US & international trademark & copyright legislation. The legal version of this report can be accessed at https://theolympiareport.com/2017/12/24/positive-news-coverage-somewhat-unlikely-to-impact-blackrock-health-sciences-trust-bme-share-price.html.
Blackrock Health Sciences Trust Company Profile
BlackRock Health Sciences Trust is a non-diversified, closed-end management investment company (the Trust). The Trust’s investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.
Receive News & Ratings for Blackrock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blackrock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.